SpinChip Diagnostics AS Revenue and Competitors

Oslo, NOR

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • SpinChip Diagnostics AS's estimated annual revenue is currently $8.6M per year.(i)
  • SpinChip Diagnostics AS's estimated revenue per employee is $126,000

Employee Data

  • SpinChip Diagnostics AS has 68 Employees.(i)
  • SpinChip Diagnostics AS grew their employee count by 11% last year.

SpinChip Diagnostics AS's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.4M249%N/AN/A
#2
$28.3M184-52%N/AN/A
#3
$8.6M6811%N/AN/A
#4
$6.8M54-8%N/AN/A
#5
$24.2M157N/AN/AN/A
#6
$2.7M28-7%N/AN/A
#7
$19.3M13834%N/AN/A
#8
$45.9M298-13%N/AN/A
#9
$1.6M19-27%N/AN/A
#10
$4.7M420%N/AN/A
Add Company

What Is SpinChip Diagnostics AS?

SpinChip Diagnostics is a medical device company who is developing a game changing and proprietary platform for in vitro diagnostics point of care analyses. The platform will make it possible to perform a broader range of analyses using one platform and to transfer analyses from central laboratories to point of care without loss in quality. All analyses are performed within a few minutes based on a fraction of a droplet of blood and at a unit cost significantly lower than other point of care platforms.

keywords:N/A

N/A

Total Funding

68

Number of Employees

$8.6M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SpinChip Diagnostics AS News

2022-04-17 - (post-pandemic Scenario) Haematology Analyzers Market Poised ...

Roche Diagnostics International • SigTuple Technologies Private Limited • SpinChip Diagnostics AS • Sysmex • T2. Biosystems • Tarabios

2022-04-17 - Haematology Analyzers Market Size, Outlook And Forecast ...

... Mindray Medical International, Noninvasix, Quotient, Roche Diagnostics International, SigTuple Technologies Private, SpinChip Diagnostics, Sysmex, T2.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.5M6831%N/A
#2
$15M683%N/A
#3
$15M683%N/A
#4
$9.2M6831%N/A
#5
$8.9M68-6%N/A